Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Transplantation and Cellular Therapy|May 24, 2025
Cumulative Dose of PEG-asparaginase Is Associated with Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukemiaJunjie Chen, Jia Li, Zhixiang Wang, et al.Oncotarget|April 16, 2016
Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCTLi Xuan, Zhiping Fan, Yu Zhang, et al.Journal of Hematology & Oncology|February 12, 2013
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter studyHui Liu, Xiao Zhai, Zhaoyang Song, et al.Transplantation and Cellular Therapy|August 19, 2025
Haploidentical hematopoietic cell transplantation combined with umbilical cord blood vs. haploidentical hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia patients: a multicenter real-world studyYifan Shen, Haiyang Lu, Jieping Lin, et al.Experimental Hematology & Oncology|April 2, 2025
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathwaysBailin He, Hong Chen, Jiaxu Wu, et al.Journal of Hematology & Oncology|October 29, 2024
Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trialJieping Lin, Zicong Huang, Zihong Cai, et al.Science Translational Medicine|September 9, 2016
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z Carter, Po Yee Mak, Hong Mu, et al.Plos One|October 15, 2013
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantationMeiqing Wu, Fen Huang, Xinmiao Jiang, et al.Cancer Letters|April 26, 2021
Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemiaYiwen Ling, Na Xu, Ke Zhao, et al.Hemasphere|May 22, 2024
An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemiaZicong Huang, Ling Zhang, Xiaoyuan Gong, et al.Pageof 10